Evidence map›Paper›PMID 32612176›Full record

ArticleNature communications2020

A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction.

Tadatoshi Sato, Shiv Verma, Christian D Castro Andrade, Maureen Omeara, Nia Campbell, Jialiang S Wang, Murat Cetinbas, Audrey Lang, Brandon J Ausk, Daniel J Brooks and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Piezoelectric Biomaterials for Bone Regeneration: Roadmap from Dipole to Osteogenesis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Tadatoshi SatoEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Shiv VermaEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Christian D Castro AndradeEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Maureen OmearaEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Nia CampbellEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Jialiang S WangEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Murat CetinbasDepartment of Molecular Biology and Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Audrey LangEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Brandon J AuskDepartment of Orthopaedics and Sports Medicine, University of Washington, Seattle, WA, USA.
Daniel J BrooksEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ruslan I SadreyevDepartment of Molecular Biology and Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Henry M KronenbergEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
David LagaresCenter for Immunology and Inflammatory Diseases, Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7317-8796
Yuhei UdaTranslational Dental Medicine, Henry M. Goldman School of Dental Medicine, Boston University, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4705-6215
Paola Divieti PajevicTranslational Dental Medicine, Henry M. Goldman School of Dental Medicine, Boston University, Boston, MA, USA.
Mary L BouxseinEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7027-7414
Ted S GrossDepartment of Orthopaedics and Sports Medicine, University of Washington, Seattle, WA, USA.
Marc N WeinEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. mnwein@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-6015-8147
Harvard University · USBeth Israel Deaconess Medical Center · USBoston University · USUniversity of Washington · USBroad Institute · US

Funding

Tissue Phenotyping CoreP01DK011794 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JUEPPNER, HARALD W. · 1986 to 2023
$44.4M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
The role of salt inducible kinases in parathyroid hormone action in boneR01DK116716 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Marc Nathan Wein · 2018 to 2026
$3.8M
Skeletal Phenotyping CoreP30AR066261 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI KRONENBERG, HENRY M. · 2014 to 2018
$3.5M
Targeting the ADAM10-sEphrin-B2 pathway in pulmonary fibrosisR01HL147059 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MEDOFF, BENJAMIN DAVID · 2019 to 2023
$2.1M
Muscle Atrophy and Bone AnabolismR01AR064735 · NIAMS · UNIVERSITY OF WASHINGTON · PI GROSS, TED S. · 2014 to 2020
$1.8M
Dissecting the roles of class IIa HDACs in osteocyte biologyK08AR067285 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI WEIN, MARC NATHAN · 2015 to 2019
$698k
A Zeiss LSM800 confocal microscope with AiryscanS10OD021577 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2016 to 2016
$374k
NHLBI NIH HHS R01 HL147059NIAMS NIH HHS K08 AR067285NIAMS NIH HHS P30 AR066261NIAMS NIH HHS R01 AR064735NIDDK NIH HHS P01 DK011794NIDDK NIH HHS P30 DK040561NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK116716NIH HHS S10 OD021577
6 · The paper itself

Abstract

Osteocytes, cells ensconced within mineralized bone matrix, are the primary skeletal mechanosensors. Osteocytes sense mechanical cues by changes in fluid flow shear stress (FFSS) across their dendritic projections. Loading-induced reductions of osteocytic Sclerostin (encoded by Sost) expression stimulates new bone formation. However, the molecular steps linking mechanotransduction and Sost suppression remain unknown. Here, we report that class IIa histone deacetylases (HDAC4 and HDAC5) are required for loading-induced Sost suppression and bone formation. FFSS signaling drives class IIa HDAC nuclear translocation through a signaling pathway involving direct HDAC5 tyrosine 642 phosphorylation by focal adhesion kinase (FAK), a HDAC5 post-translational modification that controls its subcellular localization. Osteocyte cell adhesion supports FAK tyrosine phosphorylation, and FFSS triggers FAK dephosphorylation. Pharmacologic FAK catalytic inhibition reduces Sost mRNA expression in vitro and in vivo. These studies demonstrate a role for HDAC5 as a transducer of matrix-derived cues to regulate cell type-specific gene expression.

Indexed as

AnimalsCell LineCell Line, TumorFocal Adhesion Protein-Tyrosine KinasesGene Expression ProfilingHistone DeacetylasesHumansMechanotransduction, CellularMice, Inbred C57BLMice, KnockoutOsteocytesOsteogenesisPhosphorylationSignal TransductionFocal Adhesion Protein-Tyrosine KinasesHdac5 protein, mouseHistone Deacetylases

Identifiers

PMID32612176
PMCPMC7329900
OpenAlexW3040185189

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.